2009
1
Danno K.,Ikeda M., Sekimoto M., Sugimoto T., Takemasa I., Yamamoto H., Doki Y., Monden M., Mori M. Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy Surgery145(5):457-464,2009.
2
Nakamura J.,Aoyagi S., Nanchi I., Nakatsuka S., Hirata E., Shibata S., Fukuda M., Yamamoto Y., Fukuda I., Tatsumi N., Ueda T., Fujiki F., Nomura M., Nishida S., Shirakata T., Hosen N., Tsuboi A., Oka Y., Nezu R., Mori M., Doki Y., Aozasa K., Sugiyama H., Oji Y. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycleInt J Oncol34(5):1181-1189,2009.
3
Tanemura M.,Saga A., Kawamoto K., Machida T., Deguchi T., Nishida T., Sawa Y., Doki Y., Mori M., Ito T. Intracellular and extracellular remodeling effectively prevents human CD8(+)cytotoxic T lymphocyte-mediated xenocytotoxicity by coexpression of membrane-bound human FasL and pig c-FLIP(L) in pig endothelial cellsTransplant Proc41(1):391-394,2009.
4
Tanemura M.,Saga A., Kawamoto K., Machida T., Deguchi T., Nishida T., Sawa Y., Doki Y., Mori M., Ito T. Rapamycin induces autophagy in islets: relevance in islet transplantationTransplant Proc41(1):334-338,2009.
5
Kawamoto K.,Tanemura M., Deguchi T., Machida T., Nishida T., Sawa Y., Doki Y., Mori M., Ito T. In vivo controlling of cellular response to pig islet xenografts by adenovirus-mediated expression of either membrane-bound human FasL or human decoy Fas. Transplant Proc41(1):331-333,2009.
6
Tanemura M.,Saga A., Kawamoto K., Machida T., Deguchi T., Nishida T., Sawa Y., Doki Y., Mori M., Ito T. Adenovirus-mediated gene expression of the human c-FLIP(L) gene protects pig islets against human CD8(+) cytotoxic T lymphocyte-mediated cytotoxicity Transplant Proc41(1):319-322,2009.
7
Miyoshi N.,Yano M., Takachi K., Kishi K., Noura S., Eguchi H., Yamada T., Miyashiro I., Ohue M., Ohigashi H., Sasaki Y., Ishikawa O., Doki Y., Imaoka S. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancerJ Surg Oncol99:302-306,2009.
8
Yoshioka S.,Takemasa I., Nagano H., Kittaka N., Noda T., Wada H., Kobayashi S., Marubashi S., Yakeda Y., Umeshita K., Dono K., Matsubara K., Monden M. Molecular predicition of early recurrence after resection of hepatocellular carcinomaEur J Cancer45:881-889,2009.
9
Noda T.,Nagano H., Takemasa I., Yoshioka S., Murakami M., Wada H., Kobayashi S., Marubashi S., Takeda Y., Dono K., Umeshita K., Matsuura N., Matsubara K., Doki Y., Mori M., Monden M. Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinomaBr J Cancer100(10):1647-1658,2009.
10
Akita H.,Doki Y., Yano M., Miyata H., Miyashiro I., Ohigashi H., Ishikawa O., Nishiyama A., Imaoka S. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.Dis Esophagus. 22(4):291-297,2009.
11
Ishii H.,Haraguchi N., Ieta K., Mimori K., Mori M. Cancer stem cells:gastrointestinal cancers.:155-163,2009.
12
Makino T.,Yamasaki M., Takemasa I., Takeno A., Nakamura Y., Miyata H., Takiguchi S., Fujiwara Y., Matsuura N., Mori M., Doki Y. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.Ann Surg Oncol. 16(7):2058-2064,2009.
13
Hama N.,Yanagisawa Y., Dono K., Kobayashi S., Marubashi S., Nagano H., Umeshita K., Watanabe S., Uchiyama Y., Monden M. Gene expression profiling of acute cellular rejection in rat liver transplantation using DNA microarrays.Liver Transplantation15:509-521,2009.
14
Tomimaru Y.,Takeda Y., Kobayashi S., Marubashi S., Lee MC., Tanemura M., Nagano H., Kitagawa T., Dono K., Umeshita K., Wakasa K., Monden M. Comparison of postoperative morphological changes in remnant pancreas between pancreaticojejunostomy and pancreaticogastrostomy after pancreaticoduodenectomyPancreas38(2):203-207,2009.
15
Yokobori T.,Mimori K., Iwatsuki M., Ishii H., Onoyama I., Fukagawa T., Kuwano H., Nakayama K., Mori M. p53-altered FBXW7 expression determines poor prognosis in gastric cancer casesCancer Res69(9):3788-3794,2009.
16
Mimori K.,Kataoka A., Yamaguchi H., Masuda N., Kosaka Y., Ishii H., Ohno S., Mori M. Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer casesAnn Surg Oncol16():2035-2041,2009.
17
Ieta K.,Tanaka F., Yokobori T., Kita Y., Haraguchi N., Mimori K., Kato H., Asao T., Inoue H., Kuwano H., Mori M. Clinicopathological significancer of stanniocalcin 2 gene expression in colorectal cancerInt J Cancer125():926-931,2009.
18
Tokuoka M.,Ishii H., Mimori K., Inoue H., Doki Y., Mori M. Genetic susceptibility to gastrointestinal cancer:minireview of the genomewide studiesAnn Surg Oncol16():1783-1788,2009.
19
Miyata H.,Yoshioka A., Yamasaki M., Nushijima Y., Takiguchi S., Fujiwara Y., Nishida T., Mano M., Mori M., Doki Y. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer.115(14):3324-3334,2009.
20
Motoori M.,Takemasa I., Yamasaki M., Komori T., Takeno A., Miyata H., Takiguchi S., Fujiwara Y., Yasuda T., Yano M., Matsuura N., Matsubara K., Monden M., Mori M., Doki Y. The feasibility of using biopsy samples from esophageal cancer for comprehensive gene expression profiling. Int J Oncol.35(2):265-271,2009.
21
Iwatsuki M.,Fukagawa T., Mimori K., Nakanishi H., Ito S., Yokobori T., Sasako M., Baba H., Mori M. Bone marrow and peripheral blood expression of ID/in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis.Br J Cancer100:1937-1942,2009.
22
Iwatsuki M.,Mimori K., Yokobori T., Tanaka F., Tahara K., Inoue H., Baba H., Mori M. A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer J Surg Oncol100:261-266,2009.
23
Uemura M.,Ikeda M., Sekimoto M., Haraguchi N., Mizushima T., Yamamoto H., Takemasa I., Ishii H,. Mori M. Prevention of severe pelvic abscess formation following extended radical surgery for locally recurrent rectal cancerAnn Surg Oncol16:2204-2210,2009.
24
Souma Y.,Nakajima K, Takahashi T, Nishimura J, Fujiwara Y, Takiguchi S, Miyata H,Yamasaki M, Doki Y, Nishida T. The role of intraoperative carbon dioxide insufflating upper gastrointestinal endoscopy during laparoscopic surgery.Surg Endosc.23(10):2279-2285,2009.
25
Saiki Y.,Ishimaru S., Mimori K., Takatsuno Y., Nagahara M., Ishii H., Yamada K., Mori M. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cellsSurg Oncol16:2638-2644,2009.
26
Tomimaru Y.,Nagano H., Marubashi S., Kobayashi S., Eguchi H., Takeda Y., Tanemura M,. Kitagawa T., Umeshita K., Hashimoto N., Yoshikawa H., Wakasa K., Doki Y., Mori M. Sclerosing epithelioin fibrosarcoma of the liver infiltrating the inferior vena cavaWorld Journal of Gastroenterology15(33):4204-4208,2009.
27
Mizushima T.,Nomura M., Fujii M., Akamatsu H., Mizuno H., Tominaga H., HasegawaJ., Nakajima K., Yasumasa K., Yoshikawa M., Nishida T. Primary Colorectal Signet-ring Cell Carcinoma: clinicopathological features and postoperative survivalSurgery Today:-,2009.
28
Tei M.,Ikeda M., Haraguchi N., Takemasa I., Mizushima T., Ishii H., Yamamoto H., Sekimoto M., Doki Y., Mori M. Postoperative complications in elderly patients with colorectal cancer.Comparison of open and laparoscopic surgical proceduresSurgical Laparoscopy, Endoscopy & Percutaneous Techniques.in Press
29
Miyoshi N.,Ishii H., Nagai K., Hoshino H., Mimori K., Tanaka F., Nagano H., Sekimoto M., Doki Y., Mori M. Defined factors induced reprogramming of gastrointestinal cancer cells PNAS. in Press
30
Miyoshi N.,Ishii H., Mimori K., Takatsuno Y., Kim H., Hirose H., Sekimoto M., Doki Y., Mori M. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosisBr J Cancer. in Press
31
Miyoshi N.,Ishii H., Mimori K., Tanaka F., Hitora T., Tei M., Sekimoto M., Doki Y., Mori M.TGM2 is a novel marker for prognosis in colorectal cancerAnn Surg Oncol. in Press
32
Miyoshi N.,Ishii H., Mimori K., Sekimoto M., Doki Y., Mori M. SCRN1 is a novel maeker for prognosis in colorectal cancer J Surg Oncol. in Press
33
Miyoshi N.,Ishii H., Mimori K., Sekimoto M., Doki Y., Mori M. TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancerInt J Oncol. in Press
34
Miyoshi N.,Ishii H., Mimori K., Tanaka F., Nagai K., Uemura M., Sekimoto M., Doki Y., Mori M.ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancerOncol Rep. in Press
35
Miyoshi N.,Ishii H., Sekimoto M., Doki Y., Mori M.RGS16 is a marker for prognosis in colorectal cancerAnn Surg Oncol. in Press
36
Miyoshi N.,Ishii H., Sekimoto M., Haraguchi N., Mori M.The properties and identification of cancer stem cellsSurgery Today. in Press
37
Miyoshi N.,Ohue M., Noura S., Yano M., Sasaki Y., Kishi K., Yamada T., Miyashiro I., Ohigashi H., Ishii H., Ishikawa O., Imaoka S. Surgical usefulness of indocyanine green as an alternative to India ink for endoscopic markingSurg Endosc23:347-351,2009.
38
Kobayashi S.,Nagano H., Marubashi S., Hama N., Asaoka T., Eguchi H., Takeda Y., Tanemura M., Doki Y., Mori M. Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejectionTranspl Int,2009.
39
Kobayashi S.,Nagano H., Marubashi S., Takeda Y., Tanemura M., Konishi K., Yoshioka Y., Inoue T., Doki Y., Mori M. Impact of postoperative irradiation after non-curative resection of hilar biliary cancer.J Surg Oncol,2009.
40
Sekimoto M.,Nishikawa A., Taniguchi K., Takiguchi S., Miyazaki F., Doki Y., Mori M. Development of a compact laparoscope manipulator (P-arm)Surg Endosc,.2009
41
Asaoka T.,Kato T., Marubashi S., Dono K., Hama N., Takahashi H., Kobayashi S., Takeda Y., Takemasa I., Nagano H., Yoshida H., Ruiz P., Tzakis AG., Matsubara K., Monden M., Doki Y., Mori M. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantationLiver Transpl15(12):1738-1749,2009.
42
Marubashi M.,Dono K., Nagano H., Kobayashi S., Takeda Y., Umeshita K., Monden M., Doki Y., Mori M. Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic strictureTransplantation88(9):1123-1130,2009.
43
Noda T.,Nagano H., Miyamoto A., Wada H., Murakami M., Kobayashi S., Marubashi S., Takeda Y., Dono K., Umeshita K., Wakasa K., Monden M. Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesionInt J Clin Oncol14(5):473-477,2009.
44
Wada H.,Nagano H., Yamamoto H., Noda T., Murakami M., Kobayashi S., Marubashi S., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M. Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cellsBMC Cancer12(9):361-361,2009.
45
Shimoda M.,Marubashi S., Dono K., Miyamoto A., Takeda Y., Umeshita K., Nagano H., Hoshida Y., Monden M. ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high Hepatogastroenterology56(93):1174-1177,2009.
46
Marubashi M.,Dono K., Nagano H., Kim C., Asaoka T., Hama N., Kobayashi S., Takeda Y., Umeshita K., Monden M., Doki Y., Mori M. Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic strictureClin Transplan.2009
47
Yamamoto H.,Nagasawa Y., Marubashi S., Furumatsu Y., Iwatani H., Iio K., Matsui I., Dono K., Imai E., Monden M., Isaka Y. Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplantsBlood Purif28(1):40-46,2009.
48
Marubashi M.,Nagano H., Yamanouchi E., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Maeda N., Tomoda K., Hikita H., Tsutsui S., Doki Y., Mori M. Salvage Cystic Duct Anastomosis Using a Magnetic Compression Technique for Incomplete Bile Duct Reconstruction in Living Donor Liver TransplantationLiver Transplantation.2009
49
Marubashi M.,Nagano H., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Monden M., Doki Y., Mori M. Evaluation of a New Immunoassay for Therapeutic Drug Monitoring of Tacrolimus in Adult Liver Transplant RecipientsJournal of Clinical Pharmacology.2009
50
Marubashi M.,Dono K., Nagano H., Kobayashi S., Takeda Y., Umeshita K., Monden M., Mori M.Efficacy of minimal dosage of calcineurin inhibitor for living donor liver transplant recipients with preoperative renal dysfunctionHepatogastroenterology.2009
51
Hoshino H.,Miyoshi N., Nagai K., Tomimaru Y., Nagano H., Sekimoto M., Doki Y., Mori M., Ishii H. Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancerBiochem Biophys Res Commun390(3):1061-1065,2009.
52
Miyata H.,Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol.100(6):442-446,2009.
53
Yamamoto K.,Fujiwara Y, Nishida T, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Mori M, Doki Y. Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer. Anticancer Res.29(10):4211-4215,2009.
54
Takeno A.,Takiguchi S, Yamasaki M, Miyata H, Kawabata R, Nushijima Y, Makino T, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y. A suspected [18F]fluorodeoxyglucose positron emission tomography-negative metastatic lymph node successfully diagnosed by laparoscopic staging in esophageal cancer: report of two cases.Surg Today. 39(10):888-891,2009.
55
Makino T.,Yamasaki M, Takeno A, Shirakawa M, Miyata H, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Matsuura N, Mori M, Doki Y. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus.Br J Cancer. 101(8):1298-1306,2009.
56
Akita H.,Zheng Z, Takeda Y, Kim C, Kittaka N, Kobayashi S, Marubashi S, Takemasa I, Nagano H, Dono K, Nakamori S, Monden M, Mori M, Doki Y, Bepler G. Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.Oncogene. 28(32):2903-2909,2009.
57
Akita H.,Watanabe Y, Ishida H, Nakaguchi K, Okino T, Kabuto T. A foreign body granuloma after gastric perforation mimicking peritoneal dissemination of gastric cancer: report of a case.Surg Today. 39(9):795-799,2009.
58
Sekimoto M.,Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Doki Y., Mori M. Laparoscopic reoperation of anastomotic leakage after a laparoscopic low anterior resection of the rectumInt J Colorectal Dis,2009.
59
Yamasaki M.,Miyata H., Fujiwara Y., Takiguchi S., Nakajima K., Nishida T., (Yasuda T)., (Matsuyama J)., Mori M., Doki Y. p53 genotype predicts the response to chemotherapy in patients with squamous cell carcinoma of the esophagus.Annals of Surgical Oncology,2009.
60
Makino T.,Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y. p53 mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Ann Surg Oncol.,2009.
61
Makino T.,Fujiwara Y, Takiguchi S, Miyata H, Yamasaki M, Nakajima K, Nishida T, Mori M, Doki Y.The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients. Surgery. ,2009.
62
Fujiwara.,Nishida T,. Takiguchi S,. Nakajima K,. Miyata H,. Yamasaki M,. Yamamoto K,. Moon J,. Mori M, Doki Y. Feasibility study of S-1 and intra-peritoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.Anticancer Research,2009.
63
Eguchi H.,Ohigashi H,. Takahashi H,. Yano M,. Motoori M,. Miyashiro I,. Kishi K,. Ohue M,. Noura S,. Seki Y,. Yamada T,. Goto K,. Yamamoto T,. Idota A,. Fujii J,. Nakajima H,. Yamasaki T,. Ishikawa O. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.Surgery.146(5):888-895,2009.
64
Eguchi H.,Ishikawa O,. Ohigashi H,. Takahashi H,. Ohue M,. Takenaka A,. Tomita Y,. Yano M. Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection. Am J Surg.198(5):66-71,2009.
65
Eguchi H.,Ishikawa O,. Ohigashi H,. Takahashi H,. Yano M,. Nishiyama K,. Tomita Y,. Uehara R,. Takehara A,. Nakamura Y,. Nakagawa H. Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer. Pancreas. 38(7):791-798,2009.
66
Nishida T.,（Takahashi T）., （Nishitani A）., （Doi T）., （Shirao K）., （Komatsu Y）., Nakajima K., （Hirota S）. Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT geneInt J Clin Oncol 14(2):143-149,2009.
67
Omori T.,(Oyama T)., (Mizutani S)., (Tori M)., Nakajima K, (Akamatsu H)., (Nakahara M)., (Nishida T). A simple and safe technique for esophagojejunostomy using the hemidouble stapling technique in laparoscopy-assisted total gastrectomy.Am J Surg197(1):13-17,2009.
68
Nakajima K.,Nishida T, (Takahashi T)., Souma Y, Hara J, (Yamada T)., (Yoshio T)., (Tsutsui T)., Yokoi T, Mori M, Doki Y Partial gastrectomy using natural orifice translumenal endoscopic surgery (NOTES) for gastric submucosal tumors: early experience in humans.Surg Endosc 232650-2655,2009.
69
Takahashi T.,（Endo S）., Nakajima K., Souma Y., Nishida T. Effect of Rikkunshito, a Chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy.World J Surg33:296-302,2009.
70
Endo S.,Nakajima K, (Nishikawa K)., Takahashi T,Souma Y, (Taniguchi E)., Ito T, Nishida T, Laparoscopic Heller-Dor surgery for esophageal achalasia: impact of intraoperative real-time manometric feedback on postoperative outcomes.Dig Surg26:342-348,2009.
71
Nakajima K.,Nezu R, Nomura M, Ito T, Sawa Y, Nishida T Hand-assisted laparoscopic restorative proctocolectomy for ulcerative colitis: optimization of instrumentation towards standardization.Surg Today,2009.
72
Nakajima K.,(Nezu R), (Hirota M), (Nishida T). The role of hand-assisted laparoscopic surgery in extensive colectomy for Crohn's colitis.Surg Endose,2009.
73
Hirose H.,Ishii H., Mimori K., Ohta D., Ohkuma M., Tsujii H., Saito T., Sekimoto M., Doki Y., Mori M. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumorsOncol Rep23():35-43,2009.
74
Rahadiani N.,Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Yi W, Doki Y, Aozasa K, Morii E. Tumorigenic role of podoplanin in esophageal squamous cell carcinoma. Ann Surg Oncol.,2009.
75
Qiu Y.,Song B, Zhao G, Deng B, Makino T, Tomita Y, Wang J, Luo W, Doki Y, Aozasa K, Morii E. Expression level of Pre B cell leukemia homeobox 2 (PBX2) correlates with poor prognosis of gastric adenocarcinoma and esophageal squamous cell carcinoma. Int J Oncol.,2009.
76
Yamamoto K.,Takiguchi S,. Miyata H,. Adachi S., Hiura Y., Yamasaki M,. NakajimaK,. Fujiwaｒa Y,. Mori M,. (Kangawa K)., Doki Y. Randomized phaseⅡ study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction.Surgery,.2009
77
Kobayashi S.,Nagano H., Marubashi S., Wada H., Eguchi H., Takeda Y., Tanemura M., Doki Y., Mori M. Multi-detector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancerJ Surg Oncol,2009.
78
Yamamoto H.,Hemmi H., Jinyu Gu., Sekimoto M., Doki Y., Mori M.Minute liver metastases from rectal carcinoid: a case report and review of the literatureWorld Journal of Gastrointestinal Surgery,2009.
79
Murakami M.,Tono T., Okada K., Yano H., Monden T. Fibrin glue injection method with diluted thrombin for refractory postoperative digestive fistulaAm J Surg198(5):715-719,2009.
80
Adachi S.,Takiguchi S., Okada K., Yamamoto K., Yamasaki M., Miyata H., Nakajima K., Fujiwara Y., (Hosoda H)., (Kangawa K)., Mori M., Doki Y. Effects of ghrelin administration after total gastrectomy: A prospective randomized placebo-controlled phase Ⅱ study.Gastroenterology.2009
81
Kato M.,Nakajima K., Nishida T., Yamasaki M., Nishida T., (Tsutsui S)., (Ogiyama H)., (Yamamoto S)., (Yamada T)., Mori M., Doki Y., (Hayashi N). Successful local resection of duodenal gastrointestinal stromal tumor by combined laparo-endoscopic surgeryEndoscopy,2009.
82
Domae S.,（Nakamura Y）., （Nakamura Y）., （Uenaka A）., Wada H., （Nakata M）., （Oka M）., （Kishimoto K）., （Tsukamoto G）., （Yoshihama Y）., （Matsuoka J）., （Gochi A）., （Kohno S）., （Saika T）., （Sasaki A）., （Nakayama E）., （Ono T）. Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity. Int J Cancer.124(10):2347-2352,2009.
83
Aoki M.,（Ueda S）., （Nishikawa H）., （Kitano S）., （Hirayama M）., （Ikeda H）., （Toyoda H）., （Tanaka K）., （Kanai M）., （Takabayashi A）., （Imai H）., （Shiraishi T）., （Sato E）., Wada H., （Nakayama E）., （Takei Y）., （Katayama N）., （Shiku H）., （Kageyama S）. Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.Vaccine27(49):6854-6861,2009.
84
Nagano H.,Kishimoto S., Kobayashi S., Marubashi S., Eguchi H., Takeda Y., Tanemura M., Tomimaru Y., Noda T., Umeshita K., Sakon M., Doki Y., Mori M., Monden M.A safe protocol of intermittent hilar vascular clamping for hepatic resection in cirrhosisHepatogastroenterology56:1439-1444,2009.
85
Okuyama M.,Nagano H., Kobayashi S., He L., Ota H., Shimizu J., Takeda Y., Masrubashi S., Eguchi H., Tanemuea M., Dono K., Sakon M., Umeshita K., Gotoh M., Monden M. Role of the liver in determining alloimmune response in vitro following donor-specific spleen cell injectionTranspl Immunol:-,2009.
86
Okuyama M.,(Ichida T.), Umeshita K.., (Kawasaki S.), (Mizokami M.), (Mochida S.), (Yanaga K..), Monden M., (Kiyosawa K.) Donor complications associated with living donor liver transplantation in JapanTransplantation88:110-114,2009.